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Introduction: Endovascular strategies have been increasingly used to manage patients with ruptured abdominal aortic
aneurysm (AAA) in an attempt to improve patient survival. We analyzed the evidence to support such an approach.
Methods: We performed a systematic literature review of endovascular aneurysm repair (EVAR) of ruptured AAA from
1994 to 2009. The literature analyzed included systematic reviews and population-based studies of ruptured AAA.
Results: Seven systematic reviews were identified, all demonstrating from published data that patients with EVAR of
ruptured AAA had significantly reduced mortality compared with controls. Six recently published population-based
studies from theUnited States demonstrated lowmortality rates associated with EVAR; however, only a small proportion
of ruptured AAAs were treated by EVAR. Systematic reviews and population-based studies both raised concerns about
patient selection and publication bias. Two randomized trials are in progress, and one is due to commence 2009.
Conclusions: The outcome of EVAR in a nonselected patient population remains unknown. One or more definitive
randomized trials could provide the level I evidence to resolve these issues. ( J Vasc Surg 2009;49:1077-80.)Most ruptured aneurysms worldwide are repaired by con-
ventional open surgery, with a high operative mortality and
intensive care therapies that are often costly. Some vascular
surgery units, including our own, have instigated a strategy of
using endovascular aneurysm repair (EVAR) for many pa-
tients presenting with ruptured abdominal aortic aneurysms
(AAA) because of the potential benefits in improving survival.
METHODS
We performed a systematic literature review between
1994 and 2009 using a Medline and EMBASE search of
English language publications. Key words used were “rup-
tured aneurysm,” “EVAR,” and “endovascular aneurysm
repair.” We also examined the Cochrane Central Register
of Controlled Trials database (http://www.cochrane.
org/) and two randomized trials registries for trials that are
planned, in progress, or completed (ClinicalTrials.govWeb
site at http://clinicaltrials.gov/ct2/home), and the Inter-
national Standard Randomized Controlled Trial Number
Register (http://www.isrctn.org/).
Our review focuses on the more recent data published
in large population-based studies of ruptured AAA and
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domized trials that are planned or are in progress.
RESULTS
We identified 40 case series, retrospective, and prospec-
tive studies. Some of these studies had control groups of
patients undergoing open aneurysm repair (Table I). One
pilot randomized trial and six recent population-based
studies were from the United States.1-7 In the absence of
randomized trial evidence, systematic reviews can be help-
ful. Recent reviews, seven within a 15-month period (2007
to 2008) that analyzed the contemporary literature, are
subject to strong biases. Although each review substantially
differed in design and inclusion criteria (each review ana-
lyzed between 10 and 34 studies), the mortality rates for
EVAR reported in the controlled series were lower than the
open controls.8-14
A consistent finding amongst all the reviews was study
heterogeneity and patient selection bias. Not all open sur-
gery controls were contemporaneous or well matched. A
high proportion of studies did not indicate how many
patients were turned down for EVAR on the basis of
physiologic, morphologic, or other grounds. Significant
publication bias existed, and standardized reporting criteria
were lacking. Therefore, any meta-analysis should be inter-
preted with caution.
The United States population-based studies demon-
strated a low uptake of EVAR for ruptured AAA. However,
five of the six reported a significantly improved mortality
rate in those undergoing EVAR (Table II).
The Amsterdam (Acute Endovascular Treatment to
Improve Outcome of Ruptured Aortoiliac Aneurysms
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mistically on the recruitment of just 80 patients.15 With 80
patients, there was no significant difference in primary
combined end point of 30-day mortality and serious mor-
bidity. Recruitment, which was planned to stop in late
2007, has therefore been extended twice.
The Paris-based Ruptured Aorta-Iliac Aneurysms:
Endo vs Surgery (ECAR) trial (NCT00577616) is similarly
designed to recruit only those patients who are stable and
Table I. Data from published series from 1994 to 2009 w
aortic aneurysms were compared with a control group und
First author Year Study type
Acosta 2007 Retrospective review
Alsac 2005 Case series
Anain 2007 Retrospective review
Arya 2006 Prospective intent-to-treat
Brandt 2005 Retrospective review
Castelli 2005 Retrospective review
Coppi 2006 Retrospective review
Franks 2006 Retrospective study
Hechelhammer 2005 Retrospective study
Hinchliffe 2006 Prospective randomized
Kapma 2005 Retrospective study
Lee 2004 Retrospective study
Mehta 2006 Prospective observation
Moore 2007 Prospective observation
Najjer 2007 Retrospective review
Ohki 2000 Retrospective study
Ockert 2007 Retrospective review
Peppelenbosch 2003 Prospective study
Scharrer-Pamler 2003 Retrospective review
Vaddenini 2005 Retrospective study
Visser 2006 Retrospective review
Wibmera 2008 Retrospective review
Yilmaz 2002 Retrospective review
Peppelenbosch 2006 Prospective study
Verhoeven 2009 Prospective observation
Sadat 2009 Prospective observation
EVAR, Endovascular aneurysm repair; NS, not significant.
a90 day mortality figures quoted.
Table II. Data from United States population-based stud
Study
Study period PopulationFirst author EVA
Greco3 2000-2003 Calif, Fla, NJ, NYa 290 (5
Lesperance4 2001-2004 US (NIS) 949 (1
Egorova2 1995-2004 US (Medicare) 1064 (2
Giles5 1993-2005b US (NIS) 2499 (1
McPhee6 2001-2006 US (NIS) 3179 (1
Vogel7 2001-2005 NJc 82 (1
LVC, Low-volume center; HVC, high-volume center; NIS, Nationwide Inp
aState-based data sets.
bComparative subset 2001-2005.
cState Inpatient Databases.morphologically suitable for EVAR.Unusually, patients arerandomized according to the calendar week and the hospi-
tal at which they present.
The United Kingdom-based Immediate Management
of the Patient with Rupture: Open Versus Endovascular
Repair (IMPROVE) Trial (ISRCTN48334791), a study
funded by the National Institute for Health Research
Health Technology Assessment Programme, is set up to
establish whether a strategy of preferential EVAR for rup-
tured AAA vs the current practice of open repair signifi-
outcomes of endovascular repair for ruptured abdominal
ing open surgery
atients treated by
EVAR, No.
30-day mortality, %
PEVAR Open repair
56 34 45 .16
17 23.5 50 .09
30 17 40 .19
17 24 47 .14
11 0 15 NS
25 20 25 NS
33 30 46 NS
21 11 54 NS
35 10.8 35 NS
15 53 53 NS
40 13 30 NS
13 7.69 25 NS
40 18 51 . . .
20 5 25 NS
15 6.7 13.6 NS
18 10 0 NS
29 31 31 .99
26 31 50 NS
24 20.8 40 NS
9 22 26 NS
26 31 31 NS
16 25a 29a NS
24 17 34 NS
49 35 39 NS
36 28.1 13.9 .092
17 6 17 . . .
outcomes of ruptured abdominal aortic aneurysm
relative %) Mortality, %
POpen EVAR Open
5508 (95) 39.3 47.7 .005
8982 (90) 31 42 .001
41969 (97.5) 30.4 (HVC) 38.4 (HVC) .05
57.7 (LVC) 56.4 (LVC) .05
20836 (89.3) 32.3 40.8 .001
24571 (88.5) 31.7 40.7 .0001
618 (88) 45.1 52.4 .21
Sample.here
ergo
Pies on
No. (
R
)
0)
.5)
0.7)
1.5)
2)
atientcantly reduces the 30-day and in-hospital mortality rate of
repa
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EVAR as the first approach. Trial recruitment will begin in
centers across the United Kingdom and Europe in the
summer of 2009 and should run for 3 years (Fig).
DISCUSSION
The evidence to support an EVAR-first approach for all
patients with ruptured AAA is weak and largely drawn from
three sources: results of single-center case series of EVAR
for ruptured AAA, systematic reviews, and more recently,
population-based studies arising from the United States.
Although encouraging mortality rates are published,
significant biases exist. Reports from population-based
studies may be misleading because they were unable to
control for significant confounders of patient physiology
and morphology. In addition, it is not known whether
these studies are applicable outside the United States.
If EVAR can reduce the mortality rate of patients
presenting to hospital with ruptured AAA, the manage-
ment of ruptured AAA would have to change as well as the
organization and delivery of emergency and vascular ser-
vices. One consequence of such evidence might be to
manage all ruptured AAA in large vascular centers because
evidence already demonstrates that they operate on a
higher proportion of patients with ruptured AAA and have
better outcomes for all forms of aneurysm surgery.2 The
evidence to underpin such changes must be scientifically
and clinically robust.
In the United States there has been a steady yearly rise
Fig. Design of IMPROVE (Immediate Management of
Trial (ISRCTN48334791). A&E, accident and emer
tomography; eEVAR, emergency endovascular aneurysmin the proportion of ruptured AAA treated by EVAR. In2001, 6% of cases were performed by endovascular meth-
ods, rising to 19% by 2006.6 Why is EVAR playing an
increasing role in the vascular surgeons’ armamentarium?
No doubt some surgeons are persuaded by the excellent
outcomes reported from single-center experiences. Pio-
neering centers identified the prerequisites to provide an
endovascular service for ruptured AAA patients.16 Most
large units now have computed tomography (CT) scanners
at or adjacent to the point of admission. Three-dimensional
image reconstruction software is rapid and user friendly.
The organization of an acute endovascular service has been
facilitated by the introduction of dedicated protocols, avail-
ability of surgeons trained in endovascular techniques, and
the use of hybrid operating theaters.17 Techniques have
been developed for rapid deployment of aortic occlusion
balloons and stent grafts to treat patients who are hypoten-
sive or unstable. Stent graft technology has similarly im-
proved immeasurably since the mid-1990s. Modular sys-
tems that can accommodate a large number of patients are
available off the shelf in most hospitals.
However, there are genuine concerns about the wide-
spread adoption of the endovascular technique. Data from
United States indicate a disparity in the uptake and out-
comes of EVAR between district and teaching hospitals.6
This may be partly explained by the high proportion of
tertiary transfers of more stable referrals to teaching hospit-
als (up to one-third in some institutions).17 Patient selec-
tion biases nearly all of the published series.
Other fundamental and practical issues surrounding
atient with Rupture Open Versus Endovascular repair)
; AAA, abdominal aortic aneurysm; CT, computed
ir.the P
gencythe technique remain unanswered in the current literature.
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groups may be prejudiced by an inherent delay for preop-
erative imaging. Second, anywhere between one-third and
one-half of patients presenting with ruptured AAA may
have an aneurysm that is morphologically unsuitable for
EVAR. Finally, the endovascular technique itself imparts
significant physiologic disturbance. Contrast and athero-
emboli contribute to renal failure, and there are issues
regarding the failure to seal the aneurysm (endoleak), the
morbidity of reinterventions, and the development of ab-
dominal compartment syndrome.
The only reasonable conclusion that can be drawn from
the current literature is that the role of EVAR in the
management of patients with ruptured AAA remains to be
proven. Some patients appear to do very well after EVAR,
but the paucity of quality data means that subgroup analysis
to define optimal patient characteristics has been impossi-
ble. The outcome of EVAR in a nonselected patient popu-
lation is unknown. One or more definitive randomized
trials could provide the level I evidence to resolve these
issues.
What attempts have been made to collect level I evi-
dence? The Nottingham randomized trial was abandoned
due to slow recruitment and an over-optimistic power
calculation.1 Two further randomized studies have com-
menced, the AJAX and ECAR Trials. Both have been de-
signed to recruit only themost stable patients, all ofwhomwill
be anatomically suitable for EVAR. These studies are easier to
design, and they circumnavigate the ethical dilemmas arising
as a result of randomizing cardiovascularly unstable patients.
Randomization of patients after CT scanning misses the op-
portunity to define the role of an endovascular-first strategy vs
open repair on an intention-to-treat basis.
The AJAX and ECAR trials may (or may not) show that
EVAR is better for stable patients who have suitable aneu-
rysm morphology. What evidence would be required to
promote an EVAR first policy in “all-comers?” The United
Kingdom Investigators of the IMPROVE trial believe such
a trial would have to recruit and randomize patients at
diagnosis, thus incorporating and analyzing the entire pa-
tient pathway, including any effects of patient transfer,
emergency care, and imaging. Definitive trials also should
incorporate protocols for best medical therapy (permissive
hypotension/resuscitation) and must report the numbers
and fates of patients excluded from the trials.
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